Business Wire

NC-LENOVO

16.4.2024 15:01:34 CEST | Business Wire | Press release

Share
Lenovo Embraces the AI PC Era with New ThinkCentre Desktops Powered by AMD Ryzen PRO 8000 Series Desktop Processors

Lenovo™ has unveiled a selection of ThinkCentre™ desktops powered by AMD Ryzen™ PRO 8000 Series desktop processors with up to 16 TOPS (trillion operations per second) of integrated NPU capability dedicated to process AI workloads, including the performance focused ThinkCentre M75t Gen 5, the flexible ThinkCentre M75s Gen 5, and the compact ThinkCentre M75q Gen 5. Designed to meet the diverse needs of modern business, the ThinkCentre M75 Gen 5 family of desktops harnesses the AI capability of its component while optimizing its energy efficiency to deliver impressive results.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416990902/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Lenovo ThinkCentre M75s Gen 5 (Photo: Business Wire)

“The AI PC era is already here and at Lenovo we are embracing it to unlock new possibilities,” said Sanjeev Menon, vice president and general manager, Worldwide Desktop Business in Intelligent Devices Group, Lenovo. “The need for businesses to integrate AI into their operations continues to grow and our ThinkCentre M75 family of desktops, with a strong and stable power supply, the ability to upgrade components when needed, and the space to expand memory and optimize thermal management are the ideal options to enhance productivity with AI without heavy investments. Lenovo and AMD have a long-standing partnership focused on delivering value to our customers and we know users will be delighted by the leap in performance of our new desktops.”

AI-Accelerated Performance

Designed for multitasking, the ThinkCentre M75t Gen 5 tower and ThinkCentre M75s Gen 5 small form factor desktops offer AI-accelerated power driven by an AMD Ryzen™ PRO 8000 Series desktop processor. Combined with an integrated graphics with AMD RDNA™ 3 technology, up to 64GB DDR5 (5600MHz) memory and up to 2 TB of Gen4 SSD storage1, both desktops deliver blazing speeds that makes them the ideal choice for daily commercial tasks like browsing, office, email, media and more, and to even breeze through even the most data-intensive tasks.

Smart and efficient, the ThinkCentre M75t Gen 5 and ThinkCentre M75s Gen 5 desktops become more dynamic thanks to Lenovo’s chip-level AI features, including power usage prioritization to allocate power to the correct apps when you need it, and an AI-driven fan that optimizes fan speed, so the system remains cool, and reduces noise levels. With Lenovo’s AI features, the desktops will maximize a video rendering software’s performance for content creators, increase fan speed during intense coding sessions, and even balance software performance when multitasking. The AI features continuously learn as you multitask, resulting in a smarter and more efficient workhorse as you use it.

For businesses needing expandability, both desktops offer a flexible expansion slot for hardware additions, nine USB ports for easy connectivity and the ability to support up to four independent compatible displays. Content creators, engineers, artists and those looking for more graphic options will delight in the ThinkCentre M75t Gen 5 tower desktop’s ability to host either an AMD Radeon™ RX 550 4G or AMD Radeon RX 6600LE graphic card.

Compact Performance

Compact enough to fit inside a shoe box, the ThinkCentre M75q Gen 5 is a tiny desktop with full-size performance designed to fit into virtually any location, including banking, healthcare and retail environments. Packing up to an AMD Ryzen 7 PRO 8700GE desktop processor, integrated graphics with AMD RDNA™ 3 technology and up to 64GB of dual-channel DDR5 (5200MHz) memory1, this desktop provides next-level performance while remaining small enough to hide behind a monitor.

Despite its miniature size, the ThinkCentre M75q Gen 5 is still expandable, customizable and easily upgradable. It supports seven USB connections, boasts two Gen 4 SSDs, has built-in driver support for older OS versions, can connect to three compatible displays for maximum multitasking and features toolless access to the SSD and memory module for easy expansion when needed (cards sold separately). For the most space-restricted environments, the ThinkCentre M75q Gen 5 can be mounted using a universal VESA mount to free up even more space.

Peace of Mind and Enhanced Security

The ThinkCentre M75 Gen 5 family of desktops offer more than reliable performance, they are eligible for optional Lenovo Premier Support Plus service, offering 24/7/365 peace of mind. Resolve issues quickly with easy break/fix support accessing Lenovo expert engineers for a seamless remote fix, boosting productivity and device longevity; receive proactive and preventive alerts before issues arise; benefit from next business day onsite labor and parts prioritization; enjoy Accidental Damage Protection for mishaps such as drink spills, and more.

For added security, the desktops are Secured-core PCs that come with the Microsoft Pluton security processor, offering the highest level of Windows protection. As a Windows Secured-core PC, the ThinkCentre M75 Gen 5 desktops aim to block physical attacks, protect down to the firmware level and offer extra security for even the most sensitive data.

The desktops are backed by Lenovo ThinkShield, a comprehensive end-to-end security solution that combines hardware and software to protect your data, comes with a dTPM 2.0 chip that encrypts passwords and data, a BIOS-based Smart USB protection and individual USB port disablement to help prevent unauthorized access via peripherals, and more. The ThinkCentre M75 Gen 5 family of desktops encourages businesses to innovate freely and explore the benefits of AI knowing that their data and information are protected.

Lenovo’s commitment to sustainability2 is also reflected in the lineup of ThinkCentre M75 Gen 5 desktops, with each system incorporating 85% and 95% PCC (Post-Consumer Content) plastic materials in the chassis and keyboard/mouse respectively. In addition to the use of recycled plastics, the packaging for the ThinkCentre M75 Gen 5 desktops features a thermal shell and bag made of 30% OBP (Ocean-Bound Plastic) and FSC (Forest Stewardship Council®) carton that uses material from well-managed forests and recycled sources.

To enhance the capability of the ThinkCentre M75 Gen 5 desktops, Lenovo offers an optional Smart Cable for easy USB-A and USB-C® connection to peripherals and even another laptop or tablet. Through the Smart Cable, users can control two devices using a single keyboard, mouse, or touchpad, edit data and documents on each device and even share screens.

Pricing and Availability3

  • Lenovo ThinkCentre M75t Gen 5 will not be available in North America and will be available in select global markets.
  • Lenovo ThinkCentre M75s Gen 5 is now available May 2024 with an expected starting price of $709.
  • Lenovo ThinkCentre M75q Gen 5 is now available June 2024 with an expected starting price of $749.

About Lenovo

Lenovo is a US$62 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, employing 77,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company by further expanding into growth areas that fuel the advancement of ‘New IT’ technologies (client, edge, cloud, network, and intelligence) including server, storage, mobile, software, solutions, and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992)(ADR: LNVGY). To find out more visit https://lenovo.com and read about the latest news via our StoryHub.

1 Actual available internal memory and storage capacity are less and vary due to many factors, including formatting, partitioning and operating system, etc., which utilize part of this capacity. The available capacity may change with software updates.

2 Full details of Lenovo’s commitment to sustainability found at https://www.lenovo.com/us/en/about/sustainability/

3 Prices may not include tax and do not include shipping or options and are subject to change without notice; additional terms and conditions apply. Reseller prices may vary. On-shelf dates and color options may vary by geography and products may only be available in select markets. All offers subject to availability. Lenovo reserves the right to alter product offerings, features and specifications at any time without notice.

4 Optional Features

5 EPEAT-registered where applicable — see www.epeat.net for registration status by country.

6 Requires separately purchased Wi-Fi router and plan that may vary by location. Additional terms, conditions and/or charges apply. Connection speeds will vary due to location, environment, network conditions and other factors.

LENOVO, THINKCENTRE and THINKSHIELD are trademarks of Lenovo. AMD, Radeon, Ryzen and combinations thereof are trademarks of Advanced Micro Devices, Inc. TÜV is a registered trademark of the TÜV Rheinland Group. Wi-Fi is a trademark of Wi-Fi Alliance. USB Type-C® and USB-C® are registered trademarks of USB Implementers Forum. microSD is a trademark of SD-3C, LLC. All other trademarks are the property of their respective owners. ©2024, Lenovo Group Limited.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240416990902/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye